Journal article
The role of sub-retinal fluid in determining treatment outcomes in patients with neovascular age-related macular degeneration - a phase IV randomised clinical trial with ranibizumab: the FLUID study
Jennifer J Arnold, Caroline M Markey, Nicol P Kurstjens, Robyn H Guymer
BMC Ophthalmology | BMC | Published : 2016
Grants
Funding Acknowledgements
The study is fully supported by funding from Novartis Pharmaceuticals Australia Pty Ltd.